Form 4 for GALT GALECTIN THERAPEUTICS INC
Accepted 2024-02-07 00:00:00 ET · period of report 2024-01-24 · accession 0001133416-24-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-07 | 2024-01-24 | GALT | Uihlein Richard E | Dir, 10% | A - Grant | $1.72 | +23.3K | 10.27M | +0.2% | +$40.0K |
| D | 2024-02-07 | 2024-01-24 | GALT | Uihlein Richard E | Dir, 10% | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-24 | A | A | 23,256 | $1.72 | 10,268,751 | D | — | — | (F1) These restricted shares were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan in lieu of a cash retainer and meeting fees of $40,000 for 2024. Restrictions on the shares lapse at a rate of 25% at the end of each calendar quarter in 2024. |
| 2 | Derivative | Stock Option (right to buy) | 2024-01-24 | A | A | 50,000 | $0.00 | 50,000 | D | $1.72 · — to 2034-01-24 | 50,000 Common Stock | (F3) The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan. (F4) The options vest 100% on December 31, 2024. |